Evidence map›Paper›PMID 40800322›Full record

ArticleImaging neuroscience (Cambridge, Mass.)2024

Testing PET-[

Hussein Bdair, Marie Sato-Fitoussi, Stéphane Planche, Luc Moquin, Min Su Kang, Arturo Aliaga, Atsuko Nagano-Saito, Kelly Smart, Sylvia M L Cox, Jamie Near and 8 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Imaging neuroscience (Cambridge, Mass.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Quantification of [Current neuropharmacology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Hussein BdairDepartment of Psychiatry, McGill University, Montreal, Canada.
Marie Sato-FitoussiDepartment of Psychiatry, McGill University, Montreal, Canada.
Stéphane PlancheDepartment of Psychiatry, McGill University, Montreal, Canada.
Luc MoquinDepartment of Psychiatry, Douglas Mental Health University Institute, McGill University, Montreal, Canada.
Min Su KangTranslational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer's Disease Research Unit, Douglas Research Institute, Montreal, Quebec, Canada.
Arturo AliagaDepartment of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, Montreal, Canada.
Atsuko Nagano-SaitoDepartment of Psychiatry, McGill University, Montreal, Canada.
Kelly SmartDepartment of Psychiatry, McGill University, Montreal, Canada.
Sylvia M L CoxDepartment of Psychiatry, McGill University, Montreal, Canada.
Jamie NearDepartment of Psychiatry, Douglas Mental Health University Institute, McGill University, Montreal, Canada.
Argel Aguilar-VallesDepartment of Neurosciences, Health Sciences building, Carleton University, Ottawa, Canada.
Gassan MassarwehDepartment of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, Montreal, Canada.
Pedro Rosa-NetoDepartment of Psychiatry, McGill University, Montreal, Canada.
Chawki BenkelfatDepartment of Psychiatry, McGill University, Montreal, Canada.
Jean-Paul SoucyDepartment of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, Montreal, Canada.
Alexey KostikovDepartment of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, Montreal, Canada.
Alain GrattonDepartment of Psychiatry, Douglas Mental Health University Institute, McGill University, Montreal, Canada.
Marco LeytonDepartment of Psychiatry, McGill University, Montreal, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The excitatory neurotransmitter glutamate plays a critical role inexperience-dependent neuroplasticity, including addiction-related processes. Todate, however, it is not possible to measure glutamate release in the livinghuman brain. Positron emission tomography (PET) with [

Indexed as

ethanolin vivo microdialysismagnetic resonance spectroscopymetabotropic glutamate type 5 (mGlu5) receptorspositron emission tomographytransmitter release

Identifiers

PMID40800322
PMCPMC12247555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.